Invasive Streptococcus pneumoniae in Canada, 2011–2014: Characterization of new candidate 15-valent pneumococcal conjugate vaccine serotypes 22F and 33F-Reference-Cited by-同舟云学术

Invasive Streptococcus pneumoniae in Canada, 2011–2014: Characterization of new candidate 15-valent pneumococcal conjugate vaccine serotypes 22F and 33F

Published:2016-05 Issue:23 Volume:34 Page:2527-2530
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Golden Alyssa R.,Adam Heather J.,Zhanel George G.

Funder

Research Manitoba

Streptococcus and STI Unit

University of Manitoba, Diagnostic Services Manitoba

Merck Sharp & Dohme Corp

GlaxoSmithKline

Merck and Pfizer Canada

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference20 articles.

1. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease – United States, 1998–2003;Centers for Disease Control and Prevention (CDC);Morb Mortal Wkly Rep,2005

2. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine;Pilishvili;J Infect Dis,2010

3. Safety, tolerability, and immunogenicity of 15-valent pneumococcal conjugate vaccine in healthy adults;McFetridge;Vaccine,2015

4. Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine;Kaplan;Pediatr Infect Dis J,2013

5. Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010–2012;Demczuk;Can J Microbiol,2013

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current trends in development and manufacturing of higher-valent pneumococcal polysaccharide conjugate vaccine and its challenges;Biologicals;2024-08

2. Systematic Literature Review of the Epidemiological Characteristics of Pneumococcal Disease Caused by the Additional Serotypes Covered by the 20-Valent Pneumococcal Conjugate Vaccine;Microorganisms;2023-07-15

3. Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine in Japanese healthy infants: A phase III study (V114-033);Vaccine;2023-07

4. Comparison of PCV10, PCV13, PCV15, PCV20 and PPSV23 vaccine coverage of invasive Streptococcus pneumoniae isolate serotypes in Canada: the SAVE study, 2011–20;Journal of Antimicrobial Chemotherapy;2023-05-03

5. Genomic investigation of the most common Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011–2020;Journal of Antimicrobial Chemotherapy;2023-05-03